Real-Time Blood Glucose CGM Patch Market Report 2026

Real-Time Blood Glucose CGM Patch Market Overview

• Real-Time Blood Glucose CGM Patch market size has reached to $7.05 billion in 2025 • Expected to grow to $11.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.5% • Growth Driver: The Rising Remote Monitoring And Telehealth Adoption Are Driving The Market Due To Demand For Convenient Diabetes Management • Market Trend: Innovative Water-Resistant Sensor Enhances User Convenience • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

The key promising market opportunities in the real-time blood glucose cgm patch market include: • Wearable CGM Patch (Segmentation By Product Type) → Expected gain of $3.62 Billion • Implantable CGM Patch (Segmentation By Product Type) → Expected gain of $0.89 Billion

What Is Covered Under Real-Time Blood Glucose CGM Patch Market?

A real-time blood glucose continuous glucose monitoring (CGM) patch is a wearable medical device that continuously measures glucose levels in the interstitial fluid just beneath the skin and provides real-time data. It helps individuals with diabetes monitor their blood sugar trends, detect fluctuations, and make timely adjustments to insulin or diet for better glycemic control. These patches reduce the need for frequent finger-prick testing while enabling proactive glucose control. The main product types of real-time blood continuous glucose monitoring (CGM) patch are wearable continuous glucose monitoring patches and implantable continuous glucose monitoring patches. A wearable continuous glucose monitoring patch refers to a digital health device that continuously tracks glucose levels in real-time through a sensor applied to the skin, helping manage diabetes, improve glycemic control, and support personalized treatment decisions. It utilizes various technologies such as enzymatic and non-enzymatic sensors, and is applied across various diabetes conditions such as type 1 diabetes, type 2 diabetes, gestational diabetes, and others. It is distributed through multiple channels, such as online pharmacies, retail pharmacies, hospital pharmacies, and others, serving end users such as hospitals and clinics, homecare settings, diagnostic centers, and others.

What Is The Real-Time Blood Glucose CGM Patch Market Growth Forecast?

The real-time blood glucose cgm patch market size is expected to see rapid growth in the next few years. It will grow to $11.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to AI-based glucose prediction, telehealth integration, preventive diabetes management, remote patient monitoring expansion, reimbursement policy support. Major trends in the forecast period include continuous glucose monitoring wearables, needle-free glucose tracking, real-time glucose alerts, long-duration wearable patches, improved sensor accuracy.

What Is The Driver Of The Real-Time Blood Glucose CGM Patch Market?

The rising remote monitoring and telehealth adoption are expected to propel the growth of the real-time blood glucose CGM patch market going forward. Remote monitoring refers to the use of digital technologies to collect and transmit a patient's health data, such as blood glucose levels, heart rate, or blood pressure, from outside traditional clinical settings to healthcare providers for ongoing assessment and management. Telehealth adoption, on the other hand, involves the increasing use of virtual healthcare services, including video consultations, remote follow-ups, and digital communication between patients and providers. Rising remote monitoring and telehealth adoption are increasing due to the growing demand for convenient and accessible healthcare services, especially for managing chronic conditions like diabetes. The real-time blood glucose CGM patch supports rising remote monitoring and telehealth adoption by enabling continuous, real-time data sharing with healthcare providers, allowing for timely interventions and virtual diabetes management. For instance, in February 2025, according to the American Hospital Association (AHA), a US-based national organization, the United States is projected to experience a shortage of up to 86,000 physicians by 2036, highlighting the critical role of telehealth in addressing this growing healthcare gap. Therefore, the rising remote monitoring and telehealth adoption are driving the growth of the real-time blood glucose CGM patch industry.

How Will The Drivers Impact Growth In The Global Real-Time Blood Glucose CGM Patch Market?

• Rapidly Rising Diabetes Prevalence & Screening Awareness (Medium) – During the forecast period, the growing number of diagnosed diabetes patients, along with increasing awareness around early screening and preventive monitoring, is significantly expanding the population requiring continuous glucose tracking. The rising incidence of type 2 diabetes and prediabetes, particularly among younger and urban populations, is encouraging proactive glucose management. This expanding patient base directly drives higher adoption of real-time cgm patches and supports sustained market growth. Collectively, these factors support steady market growth by directly linking research expansion with increased equipment adoption. • Rapid Technological Improvements (Medium) – During the forecast period, the increase in rapid technological improvements is expected to emerge as a major factor driving the expansion of the real-time blood glucose cgm patch market by 2030. Advances in sensor accuracy, longer wear duration, and seamless integration with mobile applications and insulin pumps enhance device reliability and user convenience. These improvements strengthen patient adherence and clinician confidence in real-time glucose data, supporting more effective diabetes management. As innovation continues to improve performance and ease of use, demand for advanced cgm patches rises steadily. • Reimbursement Coverage and Regulatory Expansions (High) – During the forecast period, the expansion of reimbursement coverage and regulatory approvals is expected to act as a key growth catalyst for the real-time blood glucose cgm patch market by 2030. Expanding reimbursement schemes and supportive regulatory approvals are increasing the affordability and availability of real-time cgm patches across broader patient groups. Insurance coverage is being extended to a larger diabetic population, including many type 2 patients, while regulatory agencies are accelerating device clearances and over-the-counter approvals. These developments reduce out-of-pocket costs, encourage physician prescriptions, and improve patient access to advanced glucose monitoring technologies. Furthermore, clearer regulatory pathways support faster product launches and wider market penetration.

How Will The Restraints Impact Growth In The Global Real-Time Blood Glucose CGM Patch Market?

• High Device Cost And Restrictive Reimbursement (Low) – During the forecast period, the high cost of real-time blood glucose cgm patches and associated monitoring systems is expected to remain a significant restraint on market growth. Advanced sensor technology, continuous monitoring capabilities, and digital connectivity features contribute to elevated device prices, making adoption challenging for cost-sensitive patients. In addition, limited reimbursement coverage and varying insurance policies across regions increase out-of-pocket expenses, reducing accessibility for a broader patient population. These financial barriers can slow market penetration, particularly in developing healthcare systems and among uninsured individuals, thereby restricting overall market expansion. • Regulatory, Safety And User-Experience Challenges (High) – During the forecast period, the regulatory, safety, and user-experience challenges are expected to hinder the growth of the real-time blood glucose cgm patch market. Manufacturers must comply with stringent regulatory requirements related to device accuracy, reliability, data security, and patient safety, which can increase development timelines and costs. Additionally, concerns regarding sensor accuracy, skin irritation, device adhesion, and calibration requirements may affect user satisfaction and long-term adoption. Variations in user experience and the need for continuous performance improvement can create barriers to widespread acceptance, limiting the pace of market growth. • Limited Sensor Lifespan And Frequent Replacement Requirement (Medium) – During the forecast period, the limited sensor lifespan and frequent replacement requirement act as a restraint for the real-time blood glucose cgm patch market by increasing the ongoing cost burden for patients and healthcare providers. The need to regularly replace sensors within short usage cycles adds to long-term treatment expenses, making continuous glucose monitoring less affordable for many users. This also creates inconvenience in usage, reducing patient adherence and consistent monitoring behavior. In addition, supply dependency for recurring consumables can strain distribution channels and inventory management. Overall, these factors limit large-scale adoption of cgm patch devices despite their clinical benefits.

Key Players In The Global Real-Time Blood Glucose CGM Patch Market

Major companies operating in the real-time blood glucose cgm patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Zhejiang POCTech Co. Ltd., MicroTech Medical Inc., Biolinq Inc., Metronom Health Inc., Afon Technology Ltd., Nemaura Medical Inc., Ultrahuman Healthcare Pvt. Ltd., PKvitality SAS, EOFlow Co. Ltd., i-SENS Inc., SiBio Technology Co. Ltd., Sinocare Inc., GlucoTrack Inc., Know Labs Inc., LifePlus Inc.

Global Real-Time Blood Glucose CGM Patch Market Trends and Insights

Major companies operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are focusing on developing innovative products, such as water-resistant sensors, to enhance user convenience and continuous monitoring reliability. A water-resistant sensor is a device designed to function accurately and continuously even when exposed to water or sweat, protecting its internal components from damage. For instance, in February 2024, Dexcom Inc., a US-based medical device company, launched the Dexcom ONE+, a real-time continuous glucose monitoring (CGM) system in Spain, Belgium, and Poland. The system offers a smaller, more accurate, and user-friendly CGM solution that provides continuous real-time glucose data 24/7 with customizable alerts, including a unique delay-first high feature to reduce alarm fatigue. It incorporates an all-in-one water-resistant sensor suitable for multiple wear locations, a rapid 30-minute warm-up, a 10-day sensor lifespan with a 12-hour grace period for sensor changes, and seamless connectivity to smartphones and receivers, supporting comprehensive diabetes management.

What Are Latest Mergers And Acquisitions In The Real-Time Blood Glucose CGM Patch Market?

In April 2025, Cardinal Health Incorporated, a US-based healthcare company, acquired Advanced Diabetes Supply Group (ADSG) for an undisclosed amount. Through this acquisition, Cardinal Health Inc. aims to expand its at-home solutions business to serve more patients with innovative diabetes care at home, accelerate growth in the growing diabetes population, and enhance its patient-centric care delivery. Advanced Diabetes Supply Group is a US-based medical equipment distributor that offers a real-time blood glucose CGM patch.

What Defines the Real-Time Blood Glucose CGM Patch Market?

The real-time blood glucose continuous glucose monitoring (CGM) patch market consists of revenues earned by entities by providing services such as continuous glucose monitoring, data analysis and reporting, remote patient monitoring, device maintenance and calibration services, and clinical trial support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time blood glucose continuous glucose monitoring (CGM) patch market also includes sales of long-wear continuous glucose monitoring patches, waterproof continuous glucose monitoring patches, wireless continuous glucose monitoring patches, pediatric continuous glucose monitoring patches, and multi-sensor continuous glucose monitoring patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Real-Time Blood Glucose CGM Patch Market Report 2026?

The real-time blood glucose cgm patch market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the real-time blood glucose cgm patch industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.